亞諾法生技股份有限公司 Approved
最後更新時間 2025/07/11 , 04:41 AM
最後更新時間 2025/07/11 , 04:41 AM
負責人
WilberHuang
統一編號
12974421
成立日期
2002/01/04
資本額
NT$800,000,000
實收資本額
NT$605,535,940
股票代號
4133
電話
87511888
地址
9F, No. 108, Zhouzih St., Xihu Vil., Neihu Dist., Taipei City, 114, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Wilber Huang Chairman 6.03%
Qiu,Qi-Jing Director 4.04% KUN MU INVESTMENT CO., LTD.
Ji,Pei-Ru Director 3.04% BO HONG INVESTMENT CO., LTD.
Chen,Yue-Hong Director 1.71% CHINA WIRE & CABLE CO., LTD.
Ye,Shao-De Independent Director 0.00%
Su,Jin-Jun Independent Director 0.00%
Cha,An-Na Independent Director 0.00%
營業項目
  • Manufacture of Medicinal Biological Products(200300)
  • Wholesale of Pharmaceutical and Medical Goods(457113)
  • 公司歷程
  • Change Person in Charge to WilberHuang
    2023/05/24
  • Change Person in Charge to WilberHuang
    2013/01/15
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 90,498 355,257 382,052
    Operating cost 50,667 191,998 208,137
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 39,831 163,259 173,915
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 39,831 163,259 173,915
    Operating expenses 33,237 128,989 126,721
    Other gain (loss), net - - -
    Operating profit (loss) 6,594 34,270 47,194
    Non-operating income and expenses 8,866 38,919 1,323
    Net profit (loss) before tax 15,460 73,189 48,517
    Income tax expense (benefits) 1,855 11,582 4,839
    Net profit (loss) of ongoing business for the current period 13,605 61,607 43,678
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 13,605 61,607 43,678
    Other comprehensive profit (loss), net 147 5,072 -910
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 13,752 66,679 42,768
    Net profit (loss) attributable to owners of parent company 13,605 61,607 43,678
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 13,752 66,679 42,768
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 0 1 0
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -5,961 50,852 76,219
    Net cash inflows (outflows) from investing activities -1,105 19,777 36,791
    Net cash inflow (outflow) from financing activities -1,366 -49,092 -55,620
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 145 3,493 -940
    Increase (decrease) in cash and cash equivalents in the current period -8,287 25,030 56,450
    Beginning balance of cash and cash equivalents 448,545 423,515 367,065
    Ending balance of cash and cash equivalents 440,258 448,545 423,515
    項目 2025 2024 2023
    Current asset 980,958 967,240 919,822
    Non-current asset 428,467 433,808 435,921
    Total asset 1,409,425 1,401,048 1,355,743
    Current liability 115,322 64,717 62,602
    Non-current liability 25,449 26,931 6,822
    Total liability 140,771 91,648 69,424
    share capital 605,536 605,536 605,536
    Equity - secruity token - 0 0
    capital reserve 474,527 474,527 474,527
    retained earning 196,036 236,929 218,455
    Other equity -7,445 -7,592 -12,199
    Treasury stock - 0 0
    Total equity attributable to owners of parent company 1,268,654 1,309,400 1,286,319
    Equity attributable to former owner of business combination under common control - 0 0
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - 0 0
    Total Equity 1,268,654 1,309,400 1,286,319
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 20 21 21
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • CTCatch
  • Wellconn Diagnostics 懷慷醫事檢驗所
  • Abnova
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Compensation for damage
    2005
  • Payment order
    2014
  • Payment, etc.
    2022
  • Pay for the goods
    2022, 2023
  • Request for payment
    2023
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。